Avenda Health's Unfold AI to be Deployed at University of Michigan Health, Expanding AI-Guided Prostate Cancer Care to the Midwest for the First Time
Summary
Avenda Health's Unfold AI platform will be deployed at University of Michigan Health's Weiser Center for Prostate Cancer, marking the first Midwest adoption. Unfold AI is an FDA-cleared, multimodal tool that combines patient data to produce a personalized 3D prostate cancer map revealing tumor size, extent, and hidden disease. Peer-reviewed data cited show substantial improvements in tumor identification (sensitivity from 37% to 97%) and prediction of local spread (92% vs. 52% for MRI alone). The product has secured a Category III CPT code from the AMA and regional Medicare payment rates, supporting clinical adoption and reimbursement. The deployment aims to give clinicians more precise treatment planning and expand access to precision prostate cancer care in the region.